Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial. [electronic resource]
Producer: 20201228Description: 1128-1139 p. digitalISSN:- 1533-3450
- Adult
- Aged
- Albuminuria -- drug therapy
- Canagliflozin -- adverse effects
- Cardiovascular Diseases -- epidemiology
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Nephropathies -- drug therapy
- Double-Blind Method
- Female
- Humans
- Kidney -- physiopathology
- Kidney Tubules, Proximal -- drug effects
- Male
- Middle Aged
- Risk
- Sodium-Glucose Transporter 2 Inhibitors -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.